Bigul

Board Meeting on May 30, 2015

Venus Remedies Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2015, inter alia, to consider and approve following items:1. To approve Audited Financial Results for the quarter ended March 31, 2015.2. To approve Audited Financial Results for the year ended on March 31, 2015.3. To issue fully convertible warrants/equity shares to promoters/persons acting in concert on a preferential...
21-05-2015
Bigul

Code of Conduct of Fair Disclosure

With reference to SEBI circular dated May 11, 2015, Disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015, Venus Remedies Ltd has submitted to BSE copy of Code of conduct and code of practice & procedures for fair disclosure of unpublished price sensitive Information adopted by the Company.Copies of disclosures are also available on Company's website.
15-05-2015
Bigul

Shareholding Pattern For March 31, 2015

Venus Remedies Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.
10-04-2015
Bigul

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Venus Remedies Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
19-02-2015
Bigul

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Merrill Lynch Capital Markets Espafia S.A, S.V has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
19-02-2015
Bigul

Financial Results for Dec 31, 2014 (Standalone)

Venus Remedies Ltd has informed BSE about the Standalone Financial Results for the period ended December 31, 2014.
13-02-2015
Bigul

Venus announces issuance of Indian Patent for Vancoplus

Venus Remedies Ltd has informed BSE regarding "Venus announces issuance of Indian Patent for Vancoplus".
09-02-2015
Bigul

Approval of Corporate Debt Restructuring

Venus Remedies Ltd has informed BSE regarding "Approval of Corporate Debt Restructuring".
29-01-2015
Bigul

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Venus Remedies Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
27-01-2015
Next Page
Close

Let's Open Free Demat Account